This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Activity 5: Intensifying Insulin Therapy in Type 2 Diabetes: Strategies for Family Medicine
The fifth in a series addressing the challenges of managing diabetes, this activity focuses on when and how to intensify insulin therapy in your patients who have type 2 diabetes. Dr. David Trachtenbarg, a family physician, talks with Dr. Amy Aronovitz, an endocrinologist, about the most challenging aspects of insulin regimens in primary care. These include transitioning patients from a basal insulin regimen to a basal/bolus insulin regimen, troubleshooting labile blood sugars, and evaluating and adjusting a basal/bolus insulin regimen.
Learning Objectives
After completing this activity, the learner will be able to:
- Describe beta-cell function decline consistent with the natural history of type 2 diabetes
- Describe the evidence-based rationale for prescribing insulin for patients who have type 2 diabetes
- Intensify insulin therapy appropriately in patients with type 2 diabetes
- Select appropriate insulin formulations and regimens based on pharmacodynamic properties and patient characteristics and lifestyle
- Use practice tools to enhance the management of type 2 diabetes
- Communicate effectively with patients regarding their need for insulin therapy, the appropriate administration of insulin and blood glucose self-monitoring techniques
Accessing the Activity
LearningLink is hosted by AAFP's technology partner MedEdArchitects. To access the activities (and to allow us to track learner progress through the program), you will need a LearningLink account. The only information required is your name, email address, and member status. Create a LearningLink account.
Begin Activity
Begin Activity
Acknowledgment of Support
This activity is supported by an educational grant from Lilly USA, LLC.
Diabetes Series
